Agalsidase Alfa and Kidney Dysfunction in Fabry DiseaseMichael L. West, Raphael Schiffmann, Bruce A. Barshop et al.|Journal of the American Society of Nephrology|2009Cited by 162
A prospective 10‐year study of individualized, intensified enzyme replacement therapy in advanced Fabry diseaseRaphael Schiffmann, Markus Ries, Caren Swift et al.|Journal of Inherited Metabolic Disease|2015Cited by 38
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfaRaphael Schiffmann, Pedro E. Huertas, Markus Ries et al.|Genetics in Medicine|2013Cited by 27
Publication rate and research topics of studies in pediatric kidney transplantationChristian Patry, Burkhard Tönshoff, Lukas Baumann et al.|Pediatric Transplantation|2022Cited by 2
Clinical trial summary of agalsidase alfa in kidney dysfunction in Fabry diseaseMelissa West, Kathy Nicholls, Archi Mehta et al.|UCL Discovery (University College London)|2009Cited by 0